50 mg capsules
Registration number: LP-002591
Pharmacotherapeutic group: Opioid receptor antagonist
Indications for use:
Treatment of alcohol dependence and blocking of the effects of exogenously injected opioids. Comprehensive treatment of opioid dependence for the purpose of maintaining a patient’s condition wherein opioids cannot have a typical effect. The medication is intended for prevention of relapses into opioid abuse after opioid intoxication.
Comprehensive treatment of alcoholism, including the maintenance therapy, at the same doses as in heroin addiction with the psychotherapy.
50 mg capsules. 10 capsules in blister packaging made from PVC film and aluminium foil. 1, 2 or 5 blister packs with instructions for use in carton packaging.